Visual Assay to Address Data Reproducibility, Integrity at SLAS 2016
Complete the form below to unlock access to ALL audio articles.
Mannix Aklian, founder and CEO of Label Independent, Inc., will present Visual Assay, a revolutionary real-time method workflow development and collaboration tool, at The Society for Laboratory Automation and Screening (SLAS) Conference and Exhibition.
Aklian’s presentation, The Visual Assay™ Platform: A Novel Mobile Assay Workflow and Project Management Tool to Ensure Data Reproducibility – Using Mobile Devices in the Lab to Capture & Share Assay Data, is scheduled for 11 a.m. on Monday, January 25. The exhibition, which is January 23-27 at the San Diego Convention Center, will feature more than 300 leading multinational providers of laboratory technology and related products and services.
During the presentation, Aklian will address the lack of data reproducibility and integrity, which is a growing concern for National Institute of Health, the pharmaceutical industry and the scientific community at large. He will detail how Visual Assay improves reproducibility and provides real-time data capture. In addition, Aklian will demonstrate how the platform encourages instant collaboration and ensures workflow compliance in research labs performing pre-clinical drug discovery.
“Reproducibility and data integrity are critical to time, cost and quality in the drug discovery process. There is a need for a tool that allows the scientist to build experiments on-the-fly, with information available before, captured during and analyzed after the experiment. We built this tool for mobile devices to ensure workflow compliance and make collaboration and data sharing instant. In the end, data is only as valuable as the methods used to generate it, and our technology makes it actionable,” Aklian said of Visual Assay.
The SLAS 2016 Conference & Exhibition brings together engineers, scientists, technologists and researchers from government, academic and commercial laboratories. The 2016 Conference highlights Advances in Bioanalytics, Biomarkers and Diagnostics, Assay Development and Screening, Automation and High-Throughput Technologies, Cellular Technologies, Drug Target Strategies, Informatics and Micro/Nano Technologies. SLAS is a global community of more than 18,000 scientists, technologists, researchers, academics, and data informatics professionals. For more information about SLAS 2016, visit slas2016.org.
